Baronsmead Second Venture Trust Reports 7.1% NAV Decline Amid Market Volatility
Baronsmead VCT reports 7.1% NAV dip amid market volatility, highlighting resilient unquoted holdings while navigating AIM sector challenges. New investments continue.
This article covers information on Baronsmead Second Venture Trust PLC.
LON:BMDNavigating the Headwinds: Baronsmead’s Half-Year Reality Check
Let’s cut straight to it: Baronsmead Second Venture Trust (BSVT) just reported a 7.1% drop in net asset value (NAV) per share for the six months to March 2025. That’s not a typo, and it’s certainly not business-as-usual for this stalwart of the VCT scene. The NAV slid from 55.2p to 51.3p, before ticking up to 54.1p by end-May. What’s behind the stumble? Buckle up – we’ve got political drama, market tremors, and a classic tale of public vs private equity resilience.
The Raw Numbers: More Than Just a NAV Dip
First, the headline stats:
- NAV Per Share: 51.3p (down from 55.2p at Sept 2024 end)
- Total NAV Return Since Launch (2001): 314.3p per £1 invested
- Funds Raised: £13.8mn (period) + £1.2mn (post-period)
- New Investments: £3.8mn (2 new unquoted, 9 follow-ons)
- Interim Dividend: 1.75p/share (declared for Sept 2025 payment)
The real story? That 7.1% drop wasn’t random noise. It was a tale of two portfolios…
Public vs Private: The Volatility Tug-of-War
Chair Sarah Fromson didn’t mince words: the “period of domestic and global political uncertainty” post-November 2024 (yes, that US election) hammered sentiment. But here’s where BSVT’s hybrid structure proved its mettle:
The Unquoted Portfolio (28% of NAV)
Flat as a pancake. Zero change in value. Why? Sheer diversification. 35% of holdings gained value (notably CitySwift and Panthera Biopartners), 35% held steady, and 30% dipped (Orri and Huma Therapeutics struggled with “extending sales cycles” – govt spending sectors like health felt the pinch). This is private equity’s superpower: insulation from daily market hysterics.
The AIM & Collective Funds (64% of NAV)
Ouch. Direct AIM holdings plunged 11.6% (vs AIM index -7.1%). The WS Gresham House funds took hits too: UK Micro Cap (-3.5%), Smaller Companies (-7.5%), Multi Cap Income (-11.5%). Blame? “National insurance and minimum wage increases” squeezing UK small-caps, despite >80% of portfolio companies meeting/exceeding expectations. Brutal.
Silver lining: Post-March, AIM holdings rebounded +4.8% in April (vs AIM +1.5%) and +5.3% in May. Volatility cuts both ways.
Deal Flow: Planting Seeds in a Storm
While markets wobbled, BSVT kept investing – strategically:
- New Unquoted: Mobility Mojo (disability access tech) & Much Better Adventures (bespoke travel)
- Post-Period Adds: Penfold Tech, Nu Quantum, Spinners (£2.8mn total)
- Follow-Ons: £2.3mn into 9 existing bets (including SecureCloud+ and Revlifter)
This isn’t reckless optimism. It’s the VCT playbook: deploy during downturns to capture value. As Fromson notes, this environment offers “high quality investments… at good prices.”
Realisation Realities: Cashing Chips Carefully
Exits were muted but telling:
- Partial AIM Sales: Cerillion (25.7x return!) and SEEEN generated £0.3mn
- Write-Offs: Crossword Cybersecurity (administration)
- Unquoted: No realisations. Patience prevails.
Translation: Managers harvested gains where possible but avoided fire sales. That Cerillion return? A reminder why we stomach the volatility.
Shareholder Pulse: New Blood & Dividend Discipline
Despite the NAV dip, investor appetite held firm:
- 526 new shareholders joined; 508 existing investors topped up
- £13.8mn raised (period); £1.2mn since
- Dividend policy remains anchored: targeting 7% yield on opening NAV (though “not a guarantee”)
The Board’s buyback policy (capping discounts at 5%) signals confidence – and liquidity matters in choppy markets.
Storm Clouds & Silver Linings: The Outlook
Fromson’s crystal ball is refreshingly candid:
- Headwinds: US/UK trade tariffs, recession risks, “materially damaged” confidence, subdued exit markets
- Tailwinds: Hybrid portfolio diversification, “sectors with long-term growth potential”, opportunistic pricing, elevated UK takeover activity (AIM exit upside)
Her verdict? “We remain committed to investing through the economic cycle.” Translation: Volatility isn’t an exit signal – it’s an entry point for disciplined VCTs.
The Takeaway: Grit Over Glitter
BSVT’s half-year reads like a masterclass in VCT reality: NAVs wobble, small-caps suffer whiplash, but well-structured portfolios weather storms. The 7.1% dip stings, but look deeper:
- Unquoted holdings held the line
- New capital flowed in (£15mn+ tax year to date)
- Deal flow didn’t freeze
- Dividends stayed on track
This isn’t a panic signal – it’s a reminder that VCT investing rewards marathon runners, not sprinters. As the trust navigates Labour’s Autumn Budget and Trump-era trade wars, that hybrid portfolio isn’t just diversification… it’s armour.
Disclosure: This is commentary, not advice. Always dig into the full RNS before any investment decision.
Related
Keep reading
Investing
Brave Bison Raises System1 Offer to £47.5 Million as Delisting Stakes Grow
Brave Bison's fourth System1 offer values the target at £47.5 million, but the deal remains conditional on securing majority support.
JoshuaSeptember 14, 2026
Investing
Keras Resources pivots to Namibian copper with US phosphate sale and £1.7 million raise
Keras Resources is reshaping itself around Namibian copper, backed by a US phosphate disposal, royalties and a £1.7 million raise.
JoshuaSeptember 14, 2026
Investing
Empyrean Energy adds Austrian gas exposure as equity fundraising looms
Empyrean Energy has agreed an Austrian gas farm-in, but shareholders face exploration risk, a trading halt and likely equity dilution.
JoshuaSeptember 14, 2026
Last updated
Category
InvestingLikes
Star Rating
No ratings yet
Comments
No comments yet - start the conversation.